BIO-key International, Inc. reported Q3’25 and 9M’25 results, with $1.55M in total revenues for Q3’25, down from $2.14M in Q3’24. The company launched the EcoID III USB fingerprint scanner and secured a new deployment in the Middle East defense sector. They also raised $3.1M in gross proceeds through a warrant exercise agreement.

The company had a net loss of ($964,849) in Q3’25, compared to ($738,959) in Q3’24. Gross margin remained strong at 77%. Operating expenses decreased by 7.8%, with total operating expenses at $2,083,908 in Q3’25. The company aims for a full-year revenue range of $6.5-$7M and expects growth in 2026.

BIO-key’s balance sheet at September 30, 2025, showed total current assets of $3.7M, including $2.0M in cash. The company raised $3.1M in gross proceeds through a warrant exercise agreement with an existing institutional investor. The net cash proceeds and shares issued are not reflected in the Q3’25 financial statements.

For the nine months ended September 30, 2025, BIO-key reported a net loss of ($2,868,790), compared to ($2,916,195) in 9M’24. The company’s cash flow from operating activities showed a net cash used of $2,838,088. Financing activities provided a net cash increase of $4,456,013, with a total of $2,039,853 in cash and cash equivalents at the end of the period.

Read more at GlobeNewswire: Digital Identity and Biometric Access Management Provider